Changing the Paradigm in Oncology Clinical Trials

AI Meets Cancer Patients and Clinical Trials

CEO and Co-Founder, Selin Kurnaz discusses how Massive Bio is changing the paradigm in oncology clinical trials at the Ai4 2nd Annual Artificial Intelligence Healthcare Conference in New York. Some of the other speakers are from top providers, payers, pharma, biotech, medical device, startups, health tech, and many more industries. This conference highlighted the advances being made in terms of applying artificial intelligence to the healthcare industry.

You can learn more about Massive Bio here. 

Media Coverage Press Releases

Leave a Comment

Your email address will not be published.

Previous reading
Cancer Patient Enrollment Improvement Key to Clinerion Partnership
Next reading
Top 128 Cancer Startups